Market Capitalization (Millions $) |
9 |
Shares
Outstanding (Millions) |
4 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-45 |
Cash Flow (TTM) (Millions $) |
-40 |
Capital Exp. (TTM) (Millions $) |
0 |
Hepion Pharmaceuticals Inc
Hepion Pharmaceuticals Inc. is a biopharmaceutical company that is focused on the development of innovative therapies for liver diseases. The company's primary area of expertise is in the research and development of drugs targeting fibrosis, a common complication of chronic liver disease. Hepion Pharmaceuticals aims to address the unmet medical needs of patients suffering from liver-related conditions by discovering and advancing novel therapeutic candidates. Their research efforts are primarily centered on developing drugs that can reduce fibrosis and improve liver function. The company is committed to bringing new treatment options to patients and improving their quality of life.
Company Address: 399 Thornall Street Edison 8837 NJ
Company Phone Number: 902-4000 Stock Exchange / Ticker: NASDAQ HEPA
HEPA is expected to report next financial results on April 09, 2024. |
|
|